[Prognostic Value of Serum Creatinine to Cystatin C Ratio in Hospitalized Patients With Chronic Obstructive Pulmonary Disease].
作者信息
Galán-Negrillo Marta, García-Pachón Eduardo
机构信息
Sección de Neumología, Hospital General Universitario de Elche, Elche (Alicante), España.
出版信息
Open Respir Arch. 2022 Jun 9;4(4):100187. doi: 10.1016/j.opresp.2022.100187. eCollection 2022 Oct-Dec.
Abstract
摘要
相似文献
1
[Prognostic Value of Serum Creatinine to Cystatin C Ratio in Hospitalized Patients With Chronic Obstructive Pulmonary Disease].
Open Respir Arch. 2022 Jun 9;4(4):100187. doi: 10.1016/j.opresp.2022.100187. eCollection 2022 Oct-Dec.
2
Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Lung. 2022 Oct;200(5):609-617. doi: 10.1007/s00408-022-00568-5. Epub 2022 Sep 15.
3
Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
Clin Nutr. 2021 Mar;40(3):1274-1280. doi: 10.1016/j.clnu.2020.08.010. Epub 2020 Aug 19.
4
The Ratio Serum Creatinine/Serum Cystatin C (a Surrogate Marker of Muscle Mass) as a Predictor of Hospitalization in Chronic Obstructive Pulmonary Disease Outpatients.
Respiration. 2019;97(4):302-309. doi: 10.1159/000494296. Epub 2018 Nov 27.
5
Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2022 Apr 8;17:781-789. doi: 10.2147/COPD.S356314. eCollection 2022.
6
Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study.
BMC Geriatr. 2023 Feb 11;23(1):89. doi: 10.1186/s12877-023-03784-7.
7
Serum Creatinine/Cystatin C Ratio Associated with Cross-Sectional Area of Erector Spinae Muscles and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2021 Dec 24;16:3513-3524. doi: 10.2147/COPD.S339243. eCollection 2021.
8
[The prognostic value of the method for determining the estimated glomerular filtration rate in chronic heart failure with a preserved left ventricular ejection fraction: focus on cystatin C].
Kardiologiia. 2019 Sep 12;59(11S):69-76. doi: 10.18087/cardio.n338.
9
Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.
BMC Pulm Med. 2022 May 23;22(1):203. doi: 10.1186/s12890-022-02000-3.
10
Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure.
Indian J Gastroenterol. 2021 Dec;40(6):563-571. doi: 10.1007/s12664-021-01201-8. Epub 2022 Jan 3.
本文引用的文献
1
[Sarcopenia index in hospitalized patients with chronic obstructive pulmonary disease exacerbation].
Medicina (B Aires). 2021;81(3):323-328.
2
The Ratio Serum Creatinine/Serum Cystatin C (a Surrogate Marker of Muscle Mass) as a Predictor of Hospitalization in Chronic Obstructive Pulmonary Disease Outpatients.
Respiration. 2019;97(4):302-309. doi: 10.1159/000494296. Epub 2018 Nov 27.
3
Sarcopenia: revised European consensus on definition and diagnosis.
Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.
4
Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index.
Crit Care Med. 2017 Jan;45(1):e23-e29. doi: 10.1097/CCM.0000000000002013.
5
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.
Thorax. 2003 Feb;58(2):100-5. doi: 10.1136/thorax.58.2.100.
Zotero 插件